Top-line Takeaways: New COVID-19 Vaccines Trials in Sub-Saharan Africa (UBUNTU trial)

Last April 6, the COVID Advocates Advisory Board (CAAB), the Coalition to Accelerate and Support Prevention Research (CASPR) and AVAC held a webinar with Dr. Nigel Garrett, from the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and international Co-chair on the COVPN 3008 Ubuntu mRNA vaccine trial.

“It is key to translate this new technology from COVID back to HIV and other diseases, and ensure Africa is part of the journey.” -Nigel Garrett

The session was moderated by Ntando Yola, co-founder and Managing Director of Community Mobilization and Engagement with Advocates for the Prevention of HIV in Africa (APHA). The aim of the webinar was to better understand the Ubuntu trial and its possible impact on people living with HIV (PLWH).

“This is really about people. It’s about communities.” -Ntando Yola

In the link, you will find the Ubuntu Top Line Takeaways of the session. Also, you can access the recording at this link